BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 26875896)

  • 21. Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML).
    Gurney M; Mangaonkar AA; Lasho T; Finke C; Al-Kali A; Gangat N; Shah MV; Alkhateeb HB; Tefferi A; Sallman D; Xie Z; Viswanatha D; Reichard K; Al Ali N; Komrokji R; Padron E; Patnaik MM
    Leukemia; 2023 Aug; 37(8):1753-1756. PubMed ID: 37422593
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical manifestation of the SRSF2 gene mutation in Chinese patients with chronic myelomonocytic leukemia.
    Sun C; Zhang S; Qiao C; Yang X; Li J
    Chin Med J (Engl); 2014; 127(24):4215-9. PubMed ID: 25533824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic myelomonocytic leukemia: myeloproliferative variant.
    Onida F; Beran M
    Curr Hematol Rep; 2004 May; 3(3):218-26. PubMed ID: 15087071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
    Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
    J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.
    Peveling-Oberhag J; Wolters F; Döring C; Walter D; Sellmann L; Scholtysik R; Lucioni M; Schubach M; Paulli M; Biskup S; Zeuzem S; Küppers R; Hansmann ML
    BMC Cancer; 2015 Oct; 15():773. PubMed ID: 26498442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases.
    Palomo L; Xicoy B; Garcia O; Mallo M; Ademà V; Cabezón M; Arnan M; Pomares H; José Larrayoz M; José Calasanz M; Maciejewski JP; Huang D; Shih LY; Ogawa S; Cervera J; Such E; Coll R; Grau J; Solé F; Zamora L
    Am J Hematol; 2016 Feb; 91(2):185-92. PubMed ID: 26509444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotyping of 25 leukemia-associated genes in a single work flow by next-generation sequencing technology with low amounts of input template DNA.
    Rinke J; Schäfer V; Schmidt M; Ziermann J; Kohlmann A; Hochhaus A; Ernst T
    Clin Chem; 2013 Aug; 59(8):1238-50. PubMed ID: 23592507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Karyotypic analysis and prognosis for 41 patients with chronic myelomonocytic leukemia].
    Lu Y; Yu MX; Mu QT; Wang Q; Chen ZM; Lou JY; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):134-7. PubMed ID: 23568720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.
    Wang SA; Galili N; Cerny J; Sechman E; Chen SS; Loew J; Liu Q; Fadare O; Hasserjian R; Jones D; Qawi H; Woda B; Raza A
    Am J Clin Pathol; 2006 Nov; 126(5):789-97. PubMed ID: 17050076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of mutations in the activation loop and juxtamembrane domains of VEGFR-1 and VEGFR-2 gene in chronic myelomonocytic leukemia (CMML).
    Such E; Cervera J; Ibáñez M; Gómez-Seguí I; Luna I; López-Pavía M; Mallo M; Collado R; Vicente A; Hernández-Boluda JC; Luño E; Andreu R; Sanz GF; Sanz MA
    Leuk Res; 2012 Mar; 36(3):e50-1. PubMed ID: 22153185
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic score including gene mutations in chronic myelomonocytic leukemia.
    Itzykson R; Kosmider O; Renneville A; Gelsi-Boyer V; Meggendorfer M; Morabito M; Berthon C; Adès L; Fenaux P; Beyne-Rauzy O; Vey N; Braun T; Haferlach T; Dreyfus F; Cross NC; Preudhomme C; Bernard OA; Fontenay M; Vainchenker W; Schnittger S; Birnbaum D; Droin N; Solary E
    J Clin Oncol; 2013 Jul; 31(19):2428-36. PubMed ID: 23690417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
    Caudill JS; Sternberg AJ; Li CY; Tefferi A; Lasho TL; Steensma DP
    Br J Haematol; 2006 Jun; 133(6):638-41. PubMed ID: 16704439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.
    Watanabe J; Sato K; Osawa Y; Horiuchi T; Kato S; Hikota-Saga R; Maekawa T; Yamamura T; Kobayashi A; Kobayashi S; Kimura F
    Int J Hematol; 2018 Jul; 108(1):47-57. PubMed ID: 29600428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y; Harada H
    Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation of the Clinical Management of CMML Patients Through In-Depth Molecular Characterization.
    Sallman DA; Padron E
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S50-5. PubMed ID: 26297278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.
    Chamseddine AN; Cabrero M; Wei Y; Ganan-Gomez I; Colla S; Takahashi K; Yang H; Bohannan ZS; Garcia-Manero G
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S67-73. PubMed ID: 27521329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients.
    Romero Arenas MA; Fowler RG; San Lucas FA; Shen J; Rich TA; Grubbs EG; Lee JE; Scheet P; Perrier ND; Zhao H
    Surgery; 2014 Dec; 156(6):1351-7; discussion 1357-8. PubMed ID: 25456907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune thrombocytopenia in chronic myelomonocytic leukemia.
    Hadjadj J; Michel M; Chauveheid MP; Godeau B; Papo T; Sacre K
    Eur J Haematol; 2014 Dec; 93(6):521-6. PubMed ID: 24913055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes.
    Wilmott JS; Field MA; Johansson PA; Kakavand H; Shang P; De Paoli-Iseppi R; Vilain RE; Pupo GM; Tembe V; Jakrot V; Shang CA; Cebon J; Shackleton M; Fitzgerald A; Thompson JF; Hayward NK; Mann GJ; Scolyer RA
    Pathology; 2015 Dec; 47(7):683-93. PubMed ID: 26517638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
    Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G
    Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.